Inventor · disambiguated record
Jörg Kallen
Also filed as: KALLEN JOERG · KALLEN JORG
6 granted patents·2 pending applications·57 citations·filing 1998–2013
80Inventor score
Technology areasA61P
Top patents by PatentIndex Score
8 records- 0175US7655666B2Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligandsNOVARTIS AG·Filed 2006·Granted Feb 2, 2010·2 cites·5 claims
- 0275US6818638B2Melvinolin derivativesNOVARTIS AG·Filed 2002·Granted Nov 16, 2004·10 cites·12 claims
- 0373US8053457B23-imidazolyl-indoles for the treatment of proliferative diseasesNOVARTIS AG·Filed 2008·Granted Nov 8, 2011·3 cites·11 claims
- 0473US6630492B1Lymphocyte function antigen-1 antagonistsNOVARTIS AG·Filed 1998·Granted Oct 7, 2003·41 cites·11 claims
- 0568US8513268B21H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsyALLGEIER HANS·Filed 2011·Granted Aug 20, 2013·1 cites·6 claims
- 0667US8012988B2N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-quinazolin-3-yl)methanesulfonamideNOVARTIS AG·Filed 2009·Granted Sep 6, 2011·0 cites·12 claims
- 0757US2013296332A11h-quinazoline-2,4-dionesNOVARTIS AG·Filed 2013·Application pending·0 cites
- 0837US2005165218A1Crystal structure of the ligand binding domain of the retinoic acid-related orphan receptor alpha (ror-alpha)Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jörg Kallen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →